BackElite Pharmaceuticals Overview
Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Discounted Cash Flow

DCF Analysis for ELTP.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.26

Current Fair Value

$0.26
29.4% Downside

Overvalued by 29.4% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading